Conflicts of interest None declared.
Expression of 25-hydroxyvitamin D3-1α-hydroxylase in subcutaneous fat necrosis
Article first published online: 22 SEP 2008
© 2008 The Authors. Journal Compilation © 2008 British Association of Dermatologists
British Journal of Dermatology
Volume 160, Issue 2, pages 423–425, February 2009
How to Cite
Farooque, A., Moss, C., Zehnder, D., Hewison, M. and Shaw, N.J. (2009), Expression of 25-hydroxyvitamin D3-1α-hydroxylase in subcutaneous fat necrosis. British Journal of Dermatology, 160: 423–425. doi: 10.1111/j.1365-2133.2008.08844.x
- Issue published online: 16 JAN 2009
- Article first published online: 22 SEP 2008
- Accepted for publication 30 June 2008
- subcutaneous fat necrosis;
- vitamin D
Background The most serious complication of subcutaneous fat necrosis (SCFN), a rare condition of the newborn characterized by indurated purple nodules, is hypercalcaemia. However, the mechanism for this hypercalcaemia remains unclear.
Objectives To determine whether the hypercalcaemia associated with SCFN involves expression of the vitamin D-activating enzyme 25-hydroxyvitamin D3-1α-hydroxylase (1α-hydroxylase) in affected tissue.
Methods Skin biopsies from two male patients with SCFN and hypercalcaemia were taken. The histological specimens were assessed using a polyclonal antibody against 1α-hydroxylase.
Results Histology in both cases showed strong expression of 1α-hydroxylase protein (brown staining) within the inflammatory infiltrate associated with SCFN. This was consistent with similar experiments in other granulomatous conditions.
Conclusions Hypercalcaemia in SCFN appears to be due to abundant levels of 1α-hydroxylase in immune infiltrates associated with tissue lesions. This is consistent with previous observations of extrarenal 1α-hydroxylase in skin from other granulomatous conditions such as sarcoidosis and slack skin disease.